PE20090961A1 - Uso de n-fenilamidas de acido 2-sulfonilaminobenzoico sustituidas con sulfonilo en el tratamiento del dolor - Google Patents
Uso de n-fenilamidas de acido 2-sulfonilaminobenzoico sustituidas con sulfonilo en el tratamiento del dolorInfo
- Publication number
- PE20090961A1 PE20090961A1 PE2008001727A PE2008001727A PE20090961A1 PE 20090961 A1 PE20090961 A1 PE 20090961A1 PE 2008001727 A PE2008001727 A PE 2008001727A PE 2008001727 A PE2008001727 A PE 2008001727A PE 20090961 A1 PE20090961 A1 PE 20090961A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- substituted
- methyl
- treatment
- trifluoromethyl
- Prior art date
Links
- NNJBQTDFDVLWEQ-UHFFFAOYSA-N 2-(sulfonylamino)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1N=S(=O)=O NNJBQTDFDVLWEQ-UHFFFAOYSA-N 0.000 title 1
- -1 C1-C4 ALKYL Chemical class 0.000 abstract 3
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical class F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 abstract 1
- RKLQLYBJAZBSEU-UHFFFAOYSA-N 5-chlorothiophene-2-sulfonamide Chemical compound NS(=O)(=O)C1=CC=C(Cl)S1 RKLQLYBJAZBSEU-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 208000023178 Musculoskeletal disease Diseases 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 208000017445 musculoskeletal system disease Diseases 0.000 abstract 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical class CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE A ES FENILENOSUSTITUIDO O NO POR HALOGENO, ALQUILO C1-C4, TRIFLUOROMETILO; R1 ES R7R8N, HET; R2 ES FENILO, HETEROARILO SUSTITUIDO O NO POR HALOGENO,ALQUILO C1-C4, TRIFLUOROMETILO, NITRO, CIANO; R3, R4, R5 Y R6 SON CADA UNO H, ALQUILO C1-C4, TRIFLUOROMETILO, CIANO, ENTRE OTROS; R7 ES H, ALQUILO C1-C4, ALQUENILO C3-C5; R8 ES ALQUILO C1-C4, CICLOALQUILO C3-C7, INDENILO, ENTRE OTROS; HET ES HETEROCICLO AROMATICO DE 5-6 MIEMBROS QUE CONTIENE 1-2 HETEROATOMOS EN EL ANILLO IGUALES O DIFERENTES. SON COMPUESTOS PREFERIDOS: HIDROCLORURO DE 2-(5-CLORO-TIOFENO-2-SULFONILAMINO)-4,5-DIMETOXI-N-(4-(N-METIL-N-(PIRIDIN-3-IL-METIL)-AMINOSULFONIL)-FENIL)-BENZAMIDA; 3-METIL-2-(4-CLRO-FENILSULFONILAMINO)-N-(4-(N-METIL-N-(2-(PIRIDIN-2-IL)-ETIL)-AMINOSULFONIL)-FENIL)-BENZAMIDA; ENTRE OTROS. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE DE DOLOR ASOCIADO CON UNA ENFERMEDAD MUSCULOESQUELETICA CRONICA
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07019521 | 2007-10-05 | ||
| EP08013725 | 2008-07-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20090961A1 true PE20090961A1 (es) | 2009-08-10 |
Family
ID=40042693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008001727A PE20090961A1 (es) | 2007-10-05 | 2008-10-03 | Uso de n-fenilamidas de acido 2-sulfonilaminobenzoico sustituidas con sulfonilo en el tratamiento del dolor |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8518998B2 (es) |
| EP (1) | EP2207541B1 (es) |
| JP (1) | JP5487107B2 (es) |
| KR (1) | KR20100063109A (es) |
| CN (1) | CN101815514B (es) |
| AR (1) | AR071049A1 (es) |
| BR (1) | BRPI0817483A2 (es) |
| CA (1) | CA2706241C (es) |
| CL (1) | CL2008002942A1 (es) |
| ES (1) | ES2527948T3 (es) |
| HK (1) | HK1143756A1 (es) |
| IL (1) | IL204668A (es) |
| MX (1) | MX2010003071A (es) |
| PA (1) | PA8797801A1 (es) |
| PE (1) | PE20090961A1 (es) |
| TW (1) | TW200932247A (es) |
| WO (1) | WO2009043495A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8569339B2 (en) | 2011-03-10 | 2013-10-29 | Boehringer Ingelheim International Gmbh | Soluble guanylate cyclase activators |
| US8815857B2 (en) | 2011-08-12 | 2014-08-26 | Boehringer Ingelheim International Gmbh | Soluble guanylate cyclase activators |
| NZ703989A (en) * | 2012-09-07 | 2017-04-28 | Boehringer Ingelheim Int | Alkoxy pyrazoles as soluble guanylate cyclase activators |
| CA2904160C (en) * | 2013-03-15 | 2022-08-23 | The California Institute For Biomedical Research | Phenyl sulfonamide derivatives and use thereof in the treatment of arthritis |
| CN106459017B (zh) | 2014-07-22 | 2020-07-17 | 勃林格殷格翰国际有限公司 | 作为可溶性鸟苷酸环化酶活化剂的杂环羧酸 |
| EP2990403A1 (en) | 2014-08-29 | 2016-03-02 | Novartis Tiergesundheit AG | Anthranilamides, sulfonamides and nitro analogues derived therefrom as anthelmintics |
| CN104892466B (zh) * | 2015-04-30 | 2018-05-29 | 中国科学技术大学 | 一种苯胺磺酰类化合物的合成及其作为hiv病毒抑制剂的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US684287A (en) | 1900-03-15 | 1901-10-08 | Millhiser Mfg Company | Bag-stringing machine. |
| TR200100147T2 (tr) | 1998-07-08 | 2001-05-21 | Aventis Pharma Deutschland Gmbh | Sülfür ile ikame edilmiş sülfonilaminokarboksilik asit N-arilamidleri |
| GB9824579D0 (en) | 1998-11-10 | 1999-01-06 | Novartis Ag | Organic compounds |
| DE19943634A1 (de) * | 1999-09-13 | 2001-04-12 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| DE10122894A1 (de) * | 2001-05-11 | 2002-11-14 | Bayer Ag | Neue Sulfonat-substituierte Pyrazolopyridinderivate |
| DOP2003000556A (es) * | 2002-01-23 | 2003-10-31 | Warner Lambert Co | Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico. |
| US20040192680A1 (en) * | 2002-12-20 | 2004-09-30 | Anderson Steven N. | Novel amides that activate soluble guanylate cyclase |
| DE102005031575A1 (de) * | 2005-07-06 | 2007-01-11 | Bayer Healthcare Ag | Verwendung von Aktivatoren der löslichen Guanylatzyklase zur Förderung der Wundheilung |
-
2008
- 2008-09-20 BR BRPI0817483A patent/BRPI0817483A2/pt not_active IP Right Cessation
- 2008-09-20 EP EP08836080.5A patent/EP2207541B1/en not_active Not-in-force
- 2008-09-20 KR KR1020107007305A patent/KR20100063109A/ko not_active Application Discontinuation
- 2008-09-20 CN CN2008801102170A patent/CN101815514B/zh not_active Expired - Fee Related
- 2008-09-20 JP JP2010527352A patent/JP5487107B2/ja not_active Expired - Fee Related
- 2008-09-20 CA CA2706241A patent/CA2706241C/en not_active Expired - Fee Related
- 2008-09-20 WO PCT/EP2008/007953 patent/WO2009043495A1/en active Application Filing
- 2008-09-20 ES ES08836080.5T patent/ES2527948T3/es active Active
- 2008-09-20 MX MX2010003071A patent/MX2010003071A/es active IP Right Grant
- 2008-10-02 AR ARP080104313A patent/AR071049A1/es not_active Application Discontinuation
- 2008-10-02 TW TW097137840A patent/TW200932247A/zh unknown
- 2008-10-02 CL CL2008002942A patent/CL2008002942A1/es unknown
- 2008-10-03 PE PE2008001727A patent/PE20090961A1/es not_active Application Discontinuation
- 2008-10-03 PA PA20088797801A patent/PA8797801A1/es unknown
-
2010
- 2010-03-22 IL IL204668A patent/IL204668A/en not_active IP Right Cessation
- 2010-03-30 US US12/749,986 patent/US8518998B2/en not_active Expired - Fee Related
- 2010-11-09 HK HK10110430.5A patent/HK1143756A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0817483A2 (pt) | 2016-07-26 |
| KR20100063109A (ko) | 2010-06-10 |
| EP2207541A1 (en) | 2010-07-21 |
| CN101815514A (zh) | 2010-08-25 |
| ES2527948T3 (es) | 2015-02-02 |
| WO2009043495A1 (en) | 2009-04-09 |
| JP2010540581A (ja) | 2010-12-24 |
| HK1143756A1 (en) | 2011-01-14 |
| CA2706241A1 (en) | 2009-04-09 |
| MX2010003071A (es) | 2010-04-01 |
| AU2008306207A1 (en) | 2009-04-09 |
| CA2706241C (en) | 2015-12-22 |
| IL204668A0 (en) | 2010-11-30 |
| JP5487107B2 (ja) | 2014-05-07 |
| US8518998B2 (en) | 2013-08-27 |
| PA8797801A1 (es) | 2009-06-23 |
| EP2207541B1 (en) | 2014-10-29 |
| US20110021505A1 (en) | 2011-01-27 |
| IL204668A (en) | 2013-10-31 |
| AR071049A1 (es) | 2010-05-26 |
| CN101815514B (zh) | 2012-05-09 |
| TW200932247A (en) | 2009-08-01 |
| CL2008002942A1 (es) | 2009-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20090961A1 (es) | Uso de n-fenilamidas de acido 2-sulfonilaminobenzoico sustituidas con sulfonilo en el tratamiento del dolor | |
| PE20180227A1 (es) | Benzamidas sustituidas con 1,3-tiazol-2-ilo | |
| PE20070528A1 (es) | Compuestos heterociclicos como ligandos del receptor vaniloide del subtipo 1 | |
| PE20061150A1 (es) | Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1) | |
| PE20090509A1 (es) | El uso de derivados de benzamida para el tratamiento de transtornos del snc | |
| PE20120119A1 (es) | AGENTES INDUCTORES DE APOPTOSIS CON SELECTIVIDAD POR Bcl-2 | |
| PE20090218A1 (es) | Compuestos mimeticos de glucocorticoides, metodos de preparacion y composiciones farmaceuticas | |
| PE20081530A1 (es) | Nuevos compuestos 617 | |
| PE20130382A1 (es) | Derivados de n-(imidazopirimidin-7-il)-heteroarilamida y su uso como inhibidores de pde10a | |
| PE20170705A1 (es) | Nuevos compuestos como inhibidores de ret (reorganizado durante la transfeccion) | |
| PE20060241A1 (es) | 2-quinolil-oxazoles sustituidos como inhibidores de pde4 | |
| PE20050691A1 (es) | Proceso para preparar carboxamidas 2-aminotiazol-5-aromaticas como inhibidores de la cinasa | |
| AR071385A1 (es) | Compuestos de 2-imino-3-metil pirrolopirimidinona sustituida con tiofenilo,composiciones farmaceuticas que los contienen,y uso de los mismos para el tratamiento de patologias asociadas con la proteina beta amiloide,tales como alzheimer y otros formas de demencia. | |
| AR060604A1 (es) | Nuevos arilamino n- heteroarilos como inhibidores de mek | |
| PE20091952A1 (es) | Compuestos de tiazole y oxazole de sulfonamida de benzeno | |
| PE20151538A1 (es) | Nuevos compuestos como inhibidores de reorganizado durante la transfeccion (ret) | |
| PE20091370A1 (es) | Arilpirrolinas insecticidas | |
| AR056103A1 (es) | Compuestos de(piran-piperidinil)benzimidazol, composiciones farmaceuticas que los comprenden, proceso de preparacion y usos en el tratamiento de afecciones mediadas por agonistas del receptor muscarinico m1 | |
| PE20081404A1 (es) | Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona y procesos para su preparacion | |
| AR056536A1 (es) | Compuestos de 2-amino-5- [4-(difluormetoxi)fenil]-5-fenilimidazolona como inhibidores de la beta secretasa (bace) | |
| PE20080543A1 (es) | Nuevos derivados de fenilo, piridina y quinolina | |
| PE20060770A1 (es) | Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina como antagonistas de los receptores cannabinoides cb1 | |
| PE20090592A1 (es) | Nuevos derivados de piperazina-amida | |
| PE20080895A1 (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas | |
| PE20140381A1 (es) | Dispersiones solidas extruidas por fusion que contienen un agente inductor de apoptosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |